Emcure Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is MEMANTINE HYDROCHLORIDE USP, with a corresponding US DMF Number 25321.
Remarkably, this DMF maintains an Active status since its submission on October 22, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 04, 2013, and payment made on January 11, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II